You are here: Industry Insights > DNA

News List

Making Sense of Antisense: The Power of Gene Silencing February 11, 2025
This article explores antisense oligonucleotides (ASOs) in gene silencing, covering their mechanism, development, applications, pros and cons, and future delivery challenges.
Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory PharmaSources
April 26, 2024
Biobatteries use enzymes to generate electricity from the breakdown of complex fuels, such as carbohydrates, fatty acids and alcohols.
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test Pharmasources
February 24, 2023
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms PharmaSources
January 28, 2025
Touchlight, a pioneer in synthetic DNA technology, appoints Will Downie as an adviser to support the strategic growth of its synthetic DNA platforms.
Ceva Animal Health and Touchlight Sign an Agreement to Use Touchlight’s dbDNA Technology in Animal Health PharmaSources
January 21, 2025
Ceva Animal Health and Touchlight sign an agreement for using dbDNA technology in animal health, aiming to develop new vaccines and therapeutics.
Did Your Gene Screen Turn Up Dangerous DNA? Study Finds Real Risk Is Low drugs.com
January 27, 2022
Most gene variants that have been labeled "pathogenic" may make only a small difference...
Chung-Ang University researchers show gold-paved path towards faster COVID-19 diagnosis ExpressPharma
January 24, 2022
Researchers use gold nanoparticles to develop a new molecular diagnostic platform that considerably reduces the time required for COVID-19 detection.
Primary Care Clinicians Tailor Colorectal Cancer Screening to Patients drugs
December 29, 2021
Clinicians, both primary care clinicians (PCCs) and gastroenterologists (GIs), prefer colonoscopy for colorectal cancer (CRC) screening of average-risk patients, according to a study published online Dec. 14 in Mayo Clinic Proceedings.
Discovering new drugs with Darwin WorldPharmaNews
December 08, 2021
Our body must constantly defend itself against bacteria and viruses. It generates millions of different antibodies, which are selected to recognise the enemy and trigger the best possible immune response. Scientists use these antibodies to for ...
Scientists identify new types of a blood cancer and potential targeted treatments WorldPharmaNews
December 01, 2021
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple...

Previous page 1 2 3 4 5 6 7 8 9 Next page